Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis

被引:0
|
作者
L. Karlsson
J. Lundkvist
E. Psachoulia
M. Intorcia
O. Ström
机构
[1] Quantify Research,Department of Learning, Informatics, Management and Ethics (LIME), Medical Management Centrum (MMC)
[2] Karolinska Institutet,Department of Pharmacy
[3] Uppsala University,undefined
[4] Amgen (Europe) GmbH,undefined
来源
Osteoporosis International | 2015年 / 26卷
关键词
Bisphosphonates; Denosumab; Meta-analysis; Persistence; Retrospective; Review;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2401 / 2411
页数:10
相关论文
共 50 条
  • [31] META-ANALYSIS OF EFFICACY AND SAFETY OF DENOSUMAB IN POSTMENOPAUSAL OSTEOPOROSIS
    Xuan, S.
    Ma, J.
    Liu, G. G.
    VALUE IN HEALTH, 2015, 18 (03) : A153 - A153
  • [32] GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
    Hadji, P.
    Kyvernitakis, I.
    Kann, P. H.
    Niedhart, C.
    Hofbauer, L. C.
    Schwarz, H.
    Kurth, A. A.
    Thomasius, F.
    Schulte, M.
    Intorcia, M.
    Psachoulia, E.
    Schmid, T.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (10) : 2967 - 2978
  • [33] GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
    P. Hadji
    I. Kyvernitakis
    P. H. Kann
    C. Niedhart
    L. C. Hofbauer
    H. Schwarz
    A. A. Kurth
    F. Thomasius
    M. Schulte
    M. Intorcia
    E. Psachoulia
    T. Schmid
    Osteoporosis International, 2016, 27 : 2967 - 2978
  • [34] A Meta-Analysis of 4 Clinical Trials of Denosumab Compared With Bisphosphonates in Postmenopausal Women Previously Treated With Oral Bisphosphonates.
    Miller, P.
    Pannacciulli, N.
    Malouf-Sierra, J.
    Singer, A.
    Czerwinski, E.
    Bone, H. G.
    Wang, C.
    Wagman, R. B.
    Brown, J. P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S271 - S271
  • [35] Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
    Park, Ji-Heh
    Park, Eun-Kyoung
    Koo, Dong-Wan
    Lee, Shinwon
    Lee, Sun-Hee
    Kim, Geun-Tae
    Lee, Seung-Geun
    BMC MUSCULOSKELETAL DISORDERS, 2017, 18
  • [36] Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
    Ji-Heh Park
    Eun-Kyoung Park
    Dong-Wan Koo
    Shinwon Lee
    Sun-Hee Lee
    Geun-Tae Kim
    Seung-Geun Lee
    BMC Musculoskeletal Disorders, 18
  • [37] Low Persistence with Oral Bisphosphonate Treatment in Portuguese Women with Postmenopausal Osteoporosis
    Torre, Carla
    Guerreiro, Jose
    Mendes, Zilda
    Miranda, Ana
    Canhao, Helena
    Branco, Jaime
    Machado, Manuela
    Ferreira, I.
    Feudjo-Tepie, M.
    Cristino, Joaquim
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 496 - 496
  • [38] Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the US
    Parthan A.
    Kruse M.
    Yurgin N.
    Huang J.
    Viswanathan H.N.
    Taylor D.
    Applied Health Economics and Health Policy, 2013, 11 (5) : 485 - 497
  • [39] Efficacy and Safety of Denosumab in Postmenopausal Women With Osteoporosis A Meta-Analysis
    Gu, Hai-Feng
    Gu, Ling-Jia
    Wu, Yue
    Zhao, Xiao-Hong
    Zhang, Qing
    Xu, Zhe-Rong
    Yang, Yun-Mei
    MEDICINE, 2015, 94 (44) : e1674
  • [40] Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
    Hoeer, Ariane
    Seidlitz, Cornelia
    Gothe, Holger
    Schiffhorst, Guido
    Olson, Melvin
    Hadji, Peyman
    Haeussler, Bertram
    PATIENT PREFERENCE AND ADHERENCE, 2009, 3 : 25 - 30